S&P 500   4,582.71 (+0.36%)
DOW   35,818.87 (+0.22%)
QQQ   379.43 (+0.40%)
AAPL   149.32 (+0.46%)
MSFT   309.69 (+0.51%)
FB   313.60 (-4.59%)
GOOGL   2,783.91 (+1.27%)
TSLA   1,034.27 (+0.92%)
AMZN   3,377.00 (+1.71%)
NVDA   247.44 (+6.81%)
BABA   170.44 (-3.25%)
NIO   40.83 (-1.07%)
CGC   13.16 (-3.02%)
GE   107.65 (+2.23%)
AMD   123.39 (+0.84%)
MU   69.07 (+0.45%)
T   25.45 (-0.74%)
F   15.89 (-0.69%)
ACB   6.97 (-2.92%)
DIS   171.83 (-0.10%)
PFE   43.49 (+0.79%)
BA   209.94 (-1.38%)
AMC   36.47 (-0.98%)
S&P 500   4,582.71 (+0.36%)
DOW   35,818.87 (+0.22%)
QQQ   379.43 (+0.40%)
AAPL   149.32 (+0.46%)
MSFT   309.69 (+0.51%)
FB   313.60 (-4.59%)
GOOGL   2,783.91 (+1.27%)
TSLA   1,034.27 (+0.92%)
AMZN   3,377.00 (+1.71%)
NVDA   247.44 (+6.81%)
BABA   170.44 (-3.25%)
NIO   40.83 (-1.07%)
CGC   13.16 (-3.02%)
GE   107.65 (+2.23%)
AMD   123.39 (+0.84%)
MU   69.07 (+0.45%)
T   25.45 (-0.74%)
F   15.89 (-0.69%)
ACB   6.97 (-2.92%)
DIS   171.83 (-0.10%)
PFE   43.49 (+0.79%)
BA   209.94 (-1.38%)
AMC   36.47 (-0.98%)
S&P 500   4,582.71 (+0.36%)
DOW   35,818.87 (+0.22%)
QQQ   379.43 (+0.40%)
AAPL   149.32 (+0.46%)
MSFT   309.69 (+0.51%)
FB   313.60 (-4.59%)
GOOGL   2,783.91 (+1.27%)
TSLA   1,034.27 (+0.92%)
AMZN   3,377.00 (+1.71%)
NVDA   247.44 (+6.81%)
BABA   170.44 (-3.25%)
NIO   40.83 (-1.07%)
CGC   13.16 (-3.02%)
GE   107.65 (+2.23%)
AMD   123.39 (+0.84%)
MU   69.07 (+0.45%)
T   25.45 (-0.74%)
F   15.89 (-0.69%)
ACB   6.97 (-2.92%)
DIS   171.83 (-0.10%)
PFE   43.49 (+0.79%)
BA   209.94 (-1.38%)
AMC   36.47 (-0.98%)
S&P 500   4,582.71 (+0.36%)
DOW   35,818.87 (+0.22%)
QQQ   379.43 (+0.40%)
AAPL   149.32 (+0.46%)
MSFT   309.69 (+0.51%)
FB   313.60 (-4.59%)
GOOGL   2,783.91 (+1.27%)
TSLA   1,034.27 (+0.92%)
AMZN   3,377.00 (+1.71%)
NVDA   247.44 (+6.81%)
BABA   170.44 (-3.25%)
NIO   40.83 (-1.07%)
CGC   13.16 (-3.02%)
GE   107.65 (+2.23%)
AMD   123.39 (+0.84%)
MU   69.07 (+0.45%)
T   25.45 (-0.74%)
F   15.89 (-0.69%)
ACB   6.97 (-2.92%)
DIS   171.83 (-0.10%)
PFE   43.49 (+0.79%)
BA   209.94 (-1.38%)
AMC   36.47 (-0.98%)
NYSE:BXC

BlueLinx Stock Forecast, Price & News

$49.50
-2.31 (-4.46 %)
(As of 10/26/2021 02:39 PM ET)
Add
Compare
Today's Range
$49.45
$51.48
50-Day Range
$48.10
$63.15
52-Week Range
$20.70
$70.38
Volume2,900 shs
Average Volume193,213 shs
Market Capitalization$481.34 million
P/E Ratio1.93
Dividend YieldN/A
Beta1.87
30 days | 90 days | 365 days | Advanced Chart
Receive BXC News and Ratings via Email

Sign-up to receive the latest news and ratings for BlueLinx and its competitors with MarketBeat's FREE daily newsletter.


BlueLinx logo

About BlueLinx

BlueLinx Holdings, Inc. engages in the distribution of building and industrial products. Its products include two principal categories: structural and specialty. The Structural products include plywood, oriented strand board, rebar and remesh, lumber, spruce and other wood products used for structural support, walls, and flooring in construction projects. The Specialty products include engineered wood products, moulding, siding, cedar, metal products, and insulation. The company was founded in May 2004 and is headquartered in Marietta, GA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Lumber, plywood, & millwork
Sub-Industry
Trading Companies & Distributors
CUSIP
09624H10
Employees
2,100
Year Founded
N/A

Sales & Book Value

Annual Sales
$3.10 billion
Cash Flow
$9.84 per share
Book Value
$6.25 per share

Profitability

Net Income
$80.88 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$481.34 million
Next Earnings Date
11/2/2021 (Confirmed)
Optionable
Optionable

MarketRank

Overall MarketRank

2.16 out of 5 stars

Construction Sector

65th out of 137 stocks

Lumber, Plywood, & Millwork Industry

1st out of 1 stocks

Analyst Opinion: 3.3Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












BlueLinx (NYSE:BXC) Frequently Asked Questions

Is BlueLinx a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BlueLinx in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BlueLinx stock.
View analyst ratings for BlueLinx
or view top-rated stocks.

What stocks does MarketBeat like better than BlueLinx?

Wall Street analysts have given BlueLinx a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BlueLinx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is BlueLinx's next earnings date?

BlueLinx is scheduled to release its next quarterly earnings announcement on Tuesday, November 2nd 2021.
View our earnings forecast for BlueLinx
.

How can I listen to BlueLinx's earnings call?

BlueLinx will be holding an earnings conference call on Wednesday, November 3rd at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 844-512-2921 with passcode "13723645".

How were BlueLinx's earnings last quarter?

BlueLinx Holdings Inc. (NYSE:BXC) released its quarterly earnings data on Monday, August, 2nd. The construction company reported $11.61 EPS for the quarter, topping the consensus estimate of $4.96 by $6.65. The construction company earned $1.31 billion during the quarter. BlueLinx had a trailing twelve-month return on equity of 213.94% and a net margin of 6.15%.
View BlueLinx's earnings history
.

How has BlueLinx's stock price been impacted by COVID-19?

BlueLinx's stock was trading at $5.53 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BXC shares have increased by 798.0% and is now trading at $49.66.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for BXC?

3 brokers have issued 12-month target prices for BlueLinx's stock. Their forecasts range from $61.00 to $85.00. On average, they expect BlueLinx's stock price to reach $70.33 in the next year. This suggests a possible upside of 41.6% from the stock's current price.
View analysts' price targets for BlueLinx
or view top-rated stocks among Wall Street analysts.

Who are BlueLinx's key executives?

BlueLinx's management team includes the following people:
  • Dwight A. K. Gibson, President & Chief Executive Officer
  • Kelly C. Janzen, Chief Financial Officer, Treasurer & Senior VP
  • Shyam K. Reddy, Co-Secretary, Chief Administrative Officer & SVP
  • Mike Wilson, Vice President-Specialty Products
  • Tom Ciarletta, Regional Vice President-East Region Sales

What is Mitch Lewis' approval rating as BlueLinx's CEO?

56 employees have rated BlueLinx CEO Mitch Lewis on Glassdoor.com. Mitch Lewis has an approval rating of 49% among BlueLinx's employees. This puts Mitch Lewis in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlueLinx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlueLinx investors own include Novavax (NVAX), Micron Technology (MU), Co-Diagnostics (CODX), Livongo Health (LVGO), Intel (INTC), Maxar Technologies (MAXR), Civeo (CVEO), Nautilus (NLS), Sorrento Therapeutics (SRNE) and Hologic (HOLX).

What is BlueLinx's stock symbol?

BlueLinx trades on the New York Stock Exchange (NYSE) under the ticker symbol "BXC."

Who are BlueLinx's major shareholders?

BlueLinx's stock is owned by a number of institutional and retail investors. Top institutional investors include Hennessy Advisors Inc. (0.76%), SummerHaven Investment Management LLC (0.22%), Exchange Traded Concepts LLC (0.10%), Islay Capital Management LLC (0.02%) and First Quadrant L P CA (0.01%). Company insiders that own BlueLinx stock include Alexander S Averitt, Brian J Sasadu, Carol B Yancey, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, Mitchell B Lewis, Nokomis Capital, LLC and Shyam K Reddy.
View institutional ownership trends for BlueLinx
.

Which major investors are selling BlueLinx stock?

BXC stock was sold by a variety of institutional investors in the last quarter, including Hennessy Advisors Inc., and Exchange Traded Concepts LLC. Company insiders that have sold BlueLinx company stock in the last year include Kim S Fennebresque, Mitchell B Lewis, Nokomis Capital, LLC, and Shyam K Reddy.
View insider buying and selling activity for BlueLinx
or view top insider-selling stocks.

Which major investors are buying BlueLinx stock?

BXC stock was bought by a variety of institutional investors in the last quarter, including SummerHaven Investment Management LLC, Islay Capital Management LLC, and First Quadrant L P CA. Company insiders that have bought BlueLinx stock in the last two years include Alexander S Averitt, Brian J Sasadu, Carol B Yancey, Kelly Janzen, Kim S Fennebresque, Mitchell B Lewis, and Shyam K Reddy.
View insider buying and selling activity for BlueLinx
or or view top insider-buying stocks.

How do I buy shares of BlueLinx?

Shares of BXC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BlueLinx's stock price today?

One share of BXC stock can currently be purchased for approximately $49.66.

How much money does BlueLinx make?

BlueLinx has a market capitalization of $482.89 million and generates $3.10 billion in revenue each year.

How many employees does BlueLinx have?

BlueLinx employs 2,100 workers across the globe.

What is BlueLinx's official website?

The official website for BlueLinx is www.bluelinxco.com.

Where are BlueLinx's headquarters?

How can I contact BlueLinx?

BlueLinx's mailing address is 1950 SPECTRUM CIRCLE SUITE 300, MARIETTA GA, 30067. The construction company can be reached via phone at (770) 953-7000 or via email at [email protected].


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.